It’s Time to Put Guardrails on GLP-1 Compounding

Consumers are inundated with false information circulating online about GLP-1 medicines, which causes confusion and can lead to potentially serious health problems resulting from dosing errors and adverse reactions to ingredients in compounded GLP-1 products. The post It’s Time to Put Guardrails on GLP-1 Compounding appeared first on MedCity News.

Read More

Drug characteristics impacting rebates

What drug characteristics lead to higher vs. lower prices in the US? A paper by Beinfeld et al. (2025) finds the answer using data from SSR Health (about rebates) and Tufts Medical Center Specialty Drug Evidence and Coverage (SPEC) database (to inform drug characteristics. Among the 161 drugs in both SSR and SPEC data, the…

Read More